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Abstract
Background: Leprosy is an infectious disease that is manifested in 
dermatological signs and symptoms and can interfere with activities 
of daily living. 
Objective: To describe the clinical and epidemiological profile of 
leprosy patients. 
Methods: A cross-sectional study was conducted with 41 patients 
diagnosed with leprosy, treated between 2011 and 2013. The SAL-
SA Scale (Screening of Activity Limitation and Safety Awareness) was 
applied to check the limitations in activities of daily living and data 
were analysed quantitatively and statistically.
Result: The patients were aged between 23 and 59 years, mostly 
male, with a high prevalence of tuberculoid leprosy, without co-mor-
bidities and outpatient discharge. The SALSA Scale score was relevant 
for individuals without limitations in domains such as mobility, self-
care, work and dexterity. 
Conclusion: Patients have few limitations for carrying out their daily 
activities, as well as a low disability level.
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Introduction
Leprosy is an infectious disease with dermatological signs and symp-
toms of slow evolution, caused by Mycobacterium leprae, an intra-
cellular parasite with tropism for skin cells and peripheral nerves [1].
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As this is a highly infectious disease with low 
pathogenicity, many individuals are infected but few 
develop the disease. It affects people of all ages, 
and of both sexes, however its incidence is higher in 
men than in women. Among the forms of disease 
transmission are direct and prolonged contact with 
a multibacillary contagious patient and untreated 
skin or mucous membranes of the upper airways [1].
Brazil accounts for 94% of leprosy cases in the 
Americas [2]. The transmission of leprosy is linked 
to socio-economic factors such as nutritional status, 
hygiene and living conditions; however, genetic fac-
tors are also linked with individuals’ predisposition 
to acquire leprosy [3].
Thus, the risk of leprosy in Brazil is related to 
major social inequalities and the disease remains 
significant as a public health problem. Research in 
2014 regarding leprosy distribution in the world 
found that the total number of detected new cases 
(180,618) was lower than in 2013 (215,656), except 
in the African region. More than 50% of cases are 
reported in areas where 17.5% of the population 
lives. Issues related to migration between endemic 
and non-endemic areas, poor housing conditions 
and sanitation and the level of social development 
are factors that affect the high endemicity of le-
prosy [4].
According to clinical and operational classifica-
tion, leprosy can be classified into paucibacillary (up 
to five skin lesions) and multibacillary (more than 
five skin lesions). Among the paucibacillary forms 
are indeterminate leprosy and tuberculoid leprosy, 
and among the multibacillary forms are borderline 
leprosy and lepromatous leprosy [5].
Criteria for classifying the physical disability of 
leprosy patients are established by the Ministry of 
Health: Level 0 (zero): no disability, there is no neu-
ral impairment in the eyes, hands and feet; Level I 
(one): presence of disability, i.e. there is a decrease 
or loss in sensibility in the eyes, hands and/or feet; 
Level II (two): presence of disabilities and deformi-
ties in the eyes (lagophthalmos, ectropion and/or 
trichiasis), hands and feet with claw and/or bone 
resorption [6].
Currently, multidrug therapy (MDT) is performed 
as a treatment and it has the function of breaking 
the epidemiological chain of the disease. As well 
as drug therapy, monitoring is carried out by the 
rehabilitation team to prevent deformities due to 
peripheral nerve injuries caused by the disease [1].
The multidrug leprosy treatment has no effect 
on the nerve fibres already damaged, hence the 
importance of health education and disability pre-
vention [7].
The causative mechanisms of deformities and di-
sabilities are neurogenic and inflammatory. Among 
the neurogenic causes considered primary are: sen-
sory, motor and autonomic deficits; and secondary: 
retractions, trauma and post-traumatic infections 
[6].
Serious injury can occur in facial peripheral nerves 
(auricular, trigeminal and facial), upper-limb nerves 
(ulnar, median and radial) and lower-limb nerves (fi-
bular and tibial). Among the injuries, there are sen-
sory disturbances (hyperesthesia and anaesthesia) 
and motor disturbances (paralysis and amyotrophy), 
plus minor deformities such as callosities, ulcera-
tions, bone resorption, loss of body hair, keratitis 
and conjunctivitis, among others [6, 7].
According to the International Classification of 
Functioning (ICF) [8], disability is defined as a ge-
neric term for deficiencies, activity limitations and 
participation restrictions. The ICF considers both the 
activities performed by an individual, such as their 
functions and social participation, indicating nega-
tive aspects of the interaction of an individual who 
has a health condition, and contextual factors, divi-
ded between environmental and personal factors.
Based on ICF, the SALSA Scale was developed to 
verify the limitation of activities performed as well 
as their risk and the awareness of risk by patients 
[6].
The high level of incapacity of leprosy has been 
the main problem associated with the disease, be-
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cause it interferes directly in the patient’s work and 
daily activities, causing economic losses, as well as 
psychological trauma because of stigma and discri-
mination [9].
The prevention of disabilities is a priority of the 
leprosy control programme, and it is present in all 
stages of treatment, including follow-up post-dis-
charge [10].
In Brazil, health centres for the care of leprosy 
patients realize the prevention of disabilities, in 
order to provide the patient with maintenance or 
improvement of their physical, socio-economic and 
emotional state. Thus, the objective is to describe 
the clinical and epidemiological profile of patients 
with leprosy.
Methods
This is a cross-sectional, exploratory and descriptive 
study, with convenience sampling and a quantita-
tive approach.
Seventy patients from the leprosy ambulatory of 
the Dermatology Centre of the Faculdade de Me-
dicina do ABC (FMABC) were contacted and, from 
these, 41 patients were chosen to participate in the 
research protocol.
The FMABC has insured outpatient clinics under 
the Unified Health System (SUS) and covers seven 
municipalities in the region: Santo André, São Ber-
nardo do Campo, São Caetano do Sul, Diadema, 
Mauá, Ribeirão Pires and Rio Grande da Serra. The 
leprosy clinic’s main function function is to follow-
up of  patients of patients through diagnostic scan-
ning, treatment and follow-up post-discharge, even 
after a cure.
Inclusion criteria were: having leprosy or having 
undergone treatment for leprosy, regardless of the 
type and classification; being older than 18, both 
sexes; voluntary participation in the study and being 
aware of the Statement of Consent. Exclusion cri-
teria were: inconclusive diagnosis of leprosy; asso-
ciated cognitive deficits and associated diseases, 
such as rheumatic, neurological and/or traumato-
orthopaedic.
For data collection, records of Simplified Neurolo-
gical Assessment recommended by the Ministry of 
Health [6] were used. Data on vision (self-reported 
as “difficult” or “without difficulty”), muscle stren-
gth (through the muscle strength test and charac-
terized as preserved or decreased) and sensitivity 
(conducted with a Semmes-Weinstein aesthesiome-
ter kit, consisting of six monofilaments of the Sorri 
Brazil brand) were collected.
Afterwards, the SALSA Scale (Screening of Acti-
vity Limitation and Safety Awareness) was applied. 
The scale consists of 20 questions, which may be 
administered in about 10 minutes, and evaluates 
the limitations of daily activities divided into cate-
gories of mobility, dexterity, self-care and work, as 
well as the awareness of risk of people with leprosy 
or other peripheral neuropathies [6, 11].
The SALSA Scale scores are distributed as follows: 
0 to 24 –without limitation; 25 to 39 –mild limita-
tion; 40 to 49 –moderate limitation; 50 to 59 –se-
vere limitation; 60 to 80 –very severe limitation [11]. 
For a risk awareness score, which ranges from 0 to 
11 points, the evaluator should add up the points 
relating to “I physically cannot” and “I avoid be-
cause of the risk”. Thus, values closer to 11 points 
indicate greater awareness of the risks involved in 
certain activities [6, 11].
Data were analysed quantitatively, using Epi Info 
version 6.0. Non-parametric statistical data were 
analysed by ANOVA (Analysis of Variance) and Krus-
kal-Wallis tests for mean differences between SALSA 
and Risk Awareness scores with the study variables 
age and vision. p values < 0.05 were considered sta-
tistically significant. 
Results
Information on the sex, working conditions and 
health of the participants are presented in Table 
1.
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Table 1.  Distribution of sex, working conditions and 
health of leprosy patients seen at the am-
bulatory of the FMABC, Santo André, São 
Paulo, Brazil, 2012-2013.
Variable N %
Sex
Male 26 63.4
Female 15 36.6
Working condition
Retired 7 17.1
Away/Unemployed 2 4.8
Housewife 6 14.6
Formal/Informal Work 26 63.4
Types of leprosy
IL 7 17.1
TL 18 43.9
BTL 1 2.4
BLL 10 24.4
LL 5 12.2
Leprosy classification
PB 25 61
MB 16 39
Secondary diagnosis
DM 3 7.3
HPN 2 4.9
DM and HPN 1 2.4
Denies diseases 35 85.4
Current condition of the disease
Ambulatory discharge 24 58.5
Treatment 17 41.5
Total 41 100
IL: indeterminate leprosy; TL: tuberculoid leprosy; 
BTL: borderline-tuberculoid leprosy; 
BLL: borderline-lepromatous leprosy; LL: lepromatous leprosy; 
PB: paucibacillary; MB: multibacillary;
 DM: diabetes mellitus; HPN: hypertension.
Table 2.  Use of adaptations, vision, muscular stren-
gth and sensibility conditions and disability 
level in patients with leprosy seen at the 
ambulatory of the FMABC, Santo André, 
Sao Paulo, Brazil, 2012-2013.
Variable N %
Use of adaptation
Yes 12 29.3
No 29 70.7
Orthose
Yes 2 4.9
No 39 95.1
Glasses
Yes 10 24.4
No 31 75.6
Vision
With difficulty 5 12.2
Without difficulty 36 87.8
Muscle strength
Preserved 33 80.5
Low 8 19.5
Sensibility
Preserved 34 82.9
Low/Moderate 5 12.2
Severe 2 4.9
Disability level
0 (Zero) 35 85.4
I (One) 1 2.4
II (Two) 5 12.2
Total 41 100
Disability level 0 – no disability; level I – presence of disability; 
level 2 – disability and deformity.
The highest prevalence of ages found in the study 
was between 23 and 59 years, of which 26 patients 
were male and 15 female.
With regard to working status, 63.4% performed 
some sort of paid activity, indicating that a large 
number of patients were active and productive so-
cially.
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When they were asked about co-morbidities, 32 
patients denied any kind of disease.
There was a prevalence of tuberculoid leprosy 
(TL – 43.9%), followed by borderline-lepromatous 
leprosy (BLL – 24.4%), of which 58.5% were in am-
bulatorial discharge and 41.5% in treatment with 
multidrug therapy.
Data in Table 2 indicate the use of adaptations, 
types of assistive technologies and degrees of disa-
bility. Most patients (70.7%) did not use any type 
of adaptation, 10 patients wore glasses and two 
wore orthoses during rest and/or for upper-limb 
positioning.
Most patients reported no problems with vision 
or loss of muscle strength, and only two patients 
showed severe loss of tactile sensitivity during sen-
sory evaluation.
With regard to the degree of disability, 35 pa-
tients (85.4%) had level 0 and only five patients 
(12.2%) had level II.
Table 3 shows the levels of limitation in ac-
tivities according to the SALSA Scale: mobility, 
self-care, work and dexterity. On this scale, 24 
patients had no limitations in daily living activities 
and only five showed moderate, severe or very 
severe limitations.
The Risk Awareness score ranged from zero to 11 
points. Zero points were found in 26 interviews and 
11 points in only one interview.
Table 4 shows the statistically significant results 
of mean differences between SALSA score and 
Risk Awareness, compared to the variables: age 
and vision.
The analyses of quantitative variables were pre-
sented as mean, minimum/maximum values and 
standard deviation. To compare mean values bet-
Table 3.  Limitation level distribution according to 
the SALSA Scale score of patients with 
leprosy seen at the ambulatory of the 
FMABC, Santo André, Sao Paulo, Brazil, 
2012-2013
Variable N %
SALSA limitation level 
No limitation 24 58.5
Mild limitation 12 29.3
Moderate limitation 1 2.4
Severe limitation 3 7.3
Very severe limitation 1 2.4
Total 41 100
SALSA Scale: Activity Limitation and Risk Awareness Screening.
Table 4.  Mean differences between SALSA score and Risk Awareness with the statistically significant stu-
dy variables (age and vision), conducted in patients with leprosy seen at the ambulatory of the 
FMABC, Santo André, Sao Paulo, Brazil, 2012-2013.
Variable N Mean Min/Max DP p Scores
SALSA Score
Age
23–59 22 48.09 23/72 15.629 0.018* 1
60–96 19 60.26 36/96 15.979 2
Risk Awareness Score
Age
23–59 27 0.63 0/6 1.597 0.027** 3
60–96 14 1.929 0/11 3.075 1
SALSA Scale Categories
Visão
Preserved 36 0.806 0/11 2.081 0.041* 2
Decreased 5 3 0/6 2.828  3
* ANOVA, ** Kruskal-Wallis
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ween SALSA and age, an ANOVA test was perfor-
med, where p = 0.018 and p = 0.041 were obtained 
for Vision and Risk Awareness Score, respectively. 
Likewise, to compare data to age and Risk Aware-
ness, there were statistically significant p-values (p 
= 0.027) in the Kruskal-Wallis test.
Discussion
This study aimed to describe the clinical-epidemiolo-
gical profile of leprosy patients from the ambulatory 
of leprosy of the FMABC.
The analysis of the categorization of leprosy pa-
tients showed a higher frequency of male patients. 
Studies with leprosy patients also found more male 
patients [12, 13].
The frequency according to age varies accor-
ding to the region analysed; however, in Brazil, 
the highest incidence is in adults [14]. The preva-
lence in age here was between 23 and 59 years 
(66%), followed by between 60 and 96 years old 
(34%). 
Among the activities mentioned by the partici-
pants, seven were retired, six were housewives, 26 
were employed, and two were unemployed and/
or laid off. Thus, 63.4% had some type of paid 
activity, indicating that a large amount of patients 
are active and socially productive. In a survey of 69 
leprosy patients in Ceará, Brazil, 79.8% had some 
occupation [15]. On the other hand, the study re-
ports on the negative impact of leprosy in terms 
of the socio-economic aspects of people affected 
by this disease, who most often are laid off and/
or retired [16]. It can thus be inferred that because 
of easy access to treatment and multiprofessional 
work, many patients remain working using their la-
bouring and everyday skills. 
When asked about co-morbidities, most denied 
any kind of associated disease; however, some re-
ported hypertension and diabetes mellitus (Table 1). 
Similarly, in a study with 26 patients, 15 denied as-
sociated diseases and the others reported changes 
in cholesterol levels, hypertension, diabetes mellitus 
and/or other diseases [17].
Serious injury may occur in the peripheral nerves 
of leprosy patients, including sensory and motor 
disturbances and deformities [18]. However, in our 
study, lesions were not observed in peripheral ner-
ves, as supported by data on the use of adaptation 
and disability level (Table 2).
With regard to the SALSA Scale, the most fre-
quent score was 24 points, showing that the majo-
rity of patients have no limitations in daily life acti-
vities. Likewise, a search more frequently obtained 
a SALSA score of 32 points [12]. However, respon-
dents here are in various stages of Risk Awareness, 
showing the need to make them aware. It was found 
that the greater the vision problem, the worse the 
score in Risk Awareness, and the higher the age, 
the worse the score on the SALSA Scale (Table 4).
In a study of 282 patients, the Risk Awareness 
score varied from 0 to 7 points, demonstrating the 
low risk perception of participants [19]. Similar re-
sults indicate that the patient has difficulty in un-
derstanding the meaning of the word “risk” when 
carrying out certain daily living activities and other 
measures should be taken to help the patient to un-
derstand the importance of discussion and risks [12].
Thus, the use of the SALSA Scale is one of the 
Brazilian Ministry of Health recommendations aimed 
at physical prevention and analysing activities with 
functional limitations, aiding in the rehabilitation of 
leprosy patients, since many patients are diagnosed 
late [6, 20].
Rehabilitation and disability prevention strategies 
over the years have been very important, and cu-
rrently professionals are aware that rehabilitation is 
an element of treatment and care of patients with 
leprosy [21].
The Guide to Leprosy Control, developed by the 
Brazilian Ministry of Health, states that treatment 
is the key to cure, and it is the strategy for the 
control and eradication of leprosy in the country. 
During multidrug therapy treatment, actions such 
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as prevention of disabilities and deformities and re-
habilitation, when necessary, should be carried out 
to the full [1].
Disability prevention techniques, when accepted 
and carried out by patients daily, contribute to mi-
nimizing or avoiding the worsening of deformities. 
Such techniques involve health education, skin hy-
dration, exercises and use of assistive technology 
[22]. Non-pharmacological interventions, neural 
monitoring, health education, exercise guidance 
and prescription orthotics in services are associated 
with the evolution of the degree of disability of 
patients [23].
After leprosy diagnosis, health education of the 
patient and family is needed, with the aim of an-
swering their questions and uniting the family in 
the assistance, treatment and rehabilitation of the 
patient [22].
In addition to physical disabilities, stigma has a 
major impact on the physical well-being, as well 
as the psychological, economic and social partici-
pation, of these subjects, making it a public health, 
social and rehabilitation issue [24].
The need to develop and implement effecti-
ve strategies to control leprosy is directly related 
to poor health-related quality of life, even in the 
cured patient, since it affects lower social classes, 
affecting the subject’s work and quality of life [25].
Besides of the high disabling potential, leprosy is 
associated with non-compliance to treatment, due 
to political, socioeconomic and cultural factors and 
lifestyle habits [26]. 
The Health care is defined by results of complex 
interactions involving the diagnosis, treatment, and 
prevention of diseases [27]. In this way, health pro-
fessionals should integrate public health practices 
to promote the health of the population [26, 27]. 
The partnership between healthcare services and 
the patient is considered as the gold standard for 
a successful result in disease healing. Patients in 
vulnerable condition, usually suffer from social ex-
clusion. Thus, the three dimensions of vulnerability 
(individual, social and programmatic) must be con-
sidered by the managers of public health [28].
To reduce the patient’s vulnerability, there is the 
need of public health planning that involves disea-
ses control e health promotion [29, 30].
The limitation of this study was due to some re-
search deviation as patient’s migration, untraceable 
or another health problem. At the beginning of 
this survey there were seventy patients that were 
supposed to participate, but unfortunately only 41 
answered the SALSA Scale.
Conclusion
The clinical and epidemiological profile of patients 
with leprosy showing as a serious service public 
health problem even today. The prevalence is bet-
ween 23 and 59 years old, of which 63.4% have 
some professional occupation. The most frequent 
type of leprosy is tuberculoid, with an incapacity 
level suggestive of the absence of deformities and 
difficulties in daily life activities. 
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